Comparison of Occipital Nerve and Sphenopalatine Ganglion Blockade - Trial NCT06243874
Access comprehensive clinical trial information for NCT06243874 through Pure Global AI's free database. This phase not specified trial is sponsored by Ankara University and is currently Completed. The study focuses on Migraine. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Ankara University
Timeline & Enrollment
N/A
Sep 01, 2023
Jan 01, 2024
Primary Outcome
Numeric Rating Scale,Migraine attack duration,Number of migraine days
Summary
Migraine is a chronic disorder that causes disability. Episodic migraine can be managed by
 prophylactic medical treatment or interventional pain procedures. Interventional methods used
 in migraine treatment are greater occipital nerve blockade, lesser occipital nerve blockade,
 supraorbital nerve blockade, infraorbital nerve blockade, sphenopalatine ganglion blockade,
 botulinum toxin injection and various radiofrequency applications. The effectiveness of
 greater occipital nerve blockade and transnasal sphenopalatine ganglion blockade in the
 treatment of migraine has been proven in various studies.We aimed to evaluate the effects of
 repetitive greater occipital nerve blockade and transnasal sphenopalatine ganglion blockade
 in patients with episodic migraine.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06243874
Non-Device Trial